106 related articles for article (PubMed ID: 30790121)
1. Comparative Serum Proteomic Analysis of the Effects of Sodium Selenate on a Mouse Model of Alzheimer's Disease.
Chen P; Wang LX; Sui XJ; Li SM; Wang Y; Liu Q; Ni JZ
Biol Trace Elem Res; 2019 Dec; 192(2):263-276. PubMed ID: 30790121
[TBL] [Abstract][Full Text] [Related]
2. Sodium selenate activated Wnt/β-catenin signaling and repressed amyloid-β formation in a triple transgenic mouse model of Alzheimer's disease.
Jin N; Zhu H; Liang X; Huang W; Xie Q; Xiao P; Ni J; Liu Q
Exp Neurol; 2017 Nov; 297():36-49. PubMed ID: 28711506
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis of serum proteins in triple transgenic Alzheimer's disease mice: implications for identifying biomarkers for use to screen potential candidate therapeutic drugs for early Alzheimer's disease.
Sui X; Ren X; Huang P; Li S; Ma Q; Ying M; Ni J; Liu J; Yang X
J Alzheimers Dis; 2014; 40(3):575-86. PubMed ID: 24496070
[TBL] [Abstract][Full Text] [Related]
4. Effect of Sodium Selenate on Hippocampal Proteome of 3×Tg-AD Mice-Exploring the Antioxidant Dogma of Selenium against Alzheimer's Disease.
Iqbal J; Zhang K; Jin N; Zhao Y; Liu Q; Ni J; Shen L
ACS Chem Neurosci; 2018 Jul; 9(7):1637-1651. PubMed ID: 29641182
[TBL] [Abstract][Full Text] [Related]
5. Selenium positively affects the proteome of 3 × Tg-AD mice cortex by altering the expression of various key proteins: unveiling the mechanistic role of selenium in AD prevention.
Iqbal J; Zhang K; Jin N; Zhao Y; Liu Q; Ni J; Shen L
J Neurosci Res; 2018 Nov; 96(11):1798-1815. PubMed ID: 30054946
[TBL] [Abstract][Full Text] [Related]
6. Identification of Novel Key Molecules Involved in Spatial Memory Impairment in Triple Transgenic Mice of Alzheimer's Disease.
Ying M; Sui X; Zhang Y; Sun Q; Qu Z; Luo X; Chang RC; Ni J; Liu J; Yang X
Mol Neurobiol; 2017 Jul; 54(5):3843-3858. PubMed ID: 27335030
[TBL] [Abstract][Full Text] [Related]
7. Reversal of memory and neuropsychiatric symptoms and reduced tau pathology by selenium in 3xTg-AD mice.
Van der Jeugd A; Parra-Damas A; Baeta-Corral R; Soto-Faguás CM; Ahmed T; LaFerla FM; Giménez-Llort L; D'Hooge R; Saura CA
Sci Rep; 2018 Apr; 8(1):6431. PubMed ID: 29691439
[TBL] [Abstract][Full Text] [Related]
8. Identification of the key molecules involved in chronic copper exposure-aggravated memory impairment in transgenic mice of Alzheimer's disease using proteomic analysis.
Yu J; Luo X; Xu H; Ma Q; Yuan J; Li X; Chang RC; Qu Z; Huang X; Zhuang Z; Liu J; Yang X
J Alzheimers Dis; 2015; 44(2):455-69. PubMed ID: 25352456
[TBL] [Abstract][Full Text] [Related]
9. Melatonin ameliorates anxiety and depression-like behaviors and modulates proteomic changes in triple transgenic mice of Alzheimer's disease.
Nie L; Wei G; Peng S; Qu Z; Yang Y; Yang Q; Huang X; Liu J; Zhuang Z; Yang X
Biofactors; 2017 Jul; 43(4):593-611. PubMed ID: 28608594
[TBL] [Abstract][Full Text] [Related]
10. Phosphoproteomic profiling of selenate-treated Alzheimer's disease model cells.
Chen P; Wang L; Wang Y; Li S; Shen L; Liu Q; Ni J
PLoS One; 2014; 9(12):e113307. PubMed ID: 25485856
[TBL] [Abstract][Full Text] [Related]
11. Sodium selenate regulates the brain ionome in a transgenic mouse model of Alzheimer's disease.
Zheng L; Zhu HZ; Wang BT; Zhao QH; Du XB; Zheng Y; Jiang L; Ni JZ; Zhang Y; Liu Q
Sci Rep; 2016 Dec; 6():39290. PubMed ID: 28008954
[TBL] [Abstract][Full Text] [Related]
12. Proteomic alterations of brain subcellular organelles caused by low-dose copper exposure: implication for Alzheimer's disease.
Yu H; Wang D; Zou L; Zhang Z; Xu H; Zhu F; Ren X; Xu B; Yuan J; Liu J; Spencer PS; Yang X
Arch Toxicol; 2018 Apr; 92(4):1363-1382. PubMed ID: 29383422
[TBL] [Abstract][Full Text] [Related]
13. Plasma protein profiling for potential biomarkers in the early diagnosis of Alzheimer's disease.
Kitamura Y; Usami R; Ichihara S; Kida H; Satoh M; Tomimoto H; Murata M; Oikawa S
Neurol Res; 2017 Mar; 39(3):231-238. PubMed ID: 28107809
[TBL] [Abstract][Full Text] [Related]
14. Selenium-enriched yeast inhibited β-amyloid production and modulated autophagy in a triple transgenic mouse model of Alzheimer's disease.
Song GL; Chen C; Wu QY; Zhang ZH; Zheng R; Chen Y; Jia SZ; Ni JZ
Metallomics; 2018 Aug; 10(8):1107-1115. PubMed ID: 30043821
[TBL] [Abstract][Full Text] [Related]
15. Redox Proteomic Profiling of Specifically Carbonylated Proteins in the Serum of Triple Transgenic Alzheimer's Disease Mice.
Shen L; Chen Y; Yang A; Chen C; Liao L; Li S; Ying M; Tian J; Liu Q; Ni J
Int J Mol Sci; 2016 Apr; 17(4):469. PubMed ID: 27077851
[TBL] [Abstract][Full Text] [Related]
16. Hydrogen sulfide slows down progression of experimental Alzheimer's disease by targeting multiple pathophysiological mechanisms.
Giuliani D; Ottani A; Zaffe D; Galantucci M; Strinati F; Lodi R; Guarini S
Neurobiol Learn Mem; 2013 Sep; 104():82-91. PubMed ID: 23726868
[TBL] [Abstract][Full Text] [Related]
17. Early dysregulation of the mitochondrial proteome in a mouse model of Alzheimer's disease.
Chou JL; Shenoy DV; Thomas N; Choudhary PK; Laferla FM; Goodman SR; Breen GA
J Proteomics; 2011 Apr; 74(4):466-79. PubMed ID: 21237293
[TBL] [Abstract][Full Text] [Related]
18. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
[TBL] [Abstract][Full Text] [Related]
19. Supranutritional Sodium Selenate Supplementation Delivers Selenium to the Central Nervous System: Results from a Randomized Controlled Pilot Trial in Alzheimer's Disease.
Cardoso BR; Roberts BR; Malpas CB; Vivash L; Genc S; Saling MM; Desmond P; Steward C; Hicks RJ; Callahan J; Brodtmann A; Collins S; Macfarlane S; Corcoran NM; Hovens CM; Velakoulis D; O'Brien TJ; Hare DJ; Bush AI
Neurotherapeutics; 2019 Jan; 16(1):192-202. PubMed ID: 30215171
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial Molecular Abnormalities Revealed by Proteomic Analysis of Hippocampal Organelles of Mice Triple Transgenic for Alzheimer Disease.
Yu H; Lin X; Wang D; Zhang Z; Guo Y; Ren X; Xu B; Yuan J; Liu J; Spencer PS; Wang JZ; Yang X
Front Mol Neurosci; 2018; 11():74. PubMed ID: 29593495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
